{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:30:33Z","timestamp":1790386233386,"version":"4.1.0"},"reference-count":44,"publisher":"Portland Press Ltd.","issue":"5","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":303,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,10,31]]},"abstract":"<jats:p>It is established that the immunogenicity of polysaccharides is enhanced by coupling them to carrier proteins. Cross reacting material (CRM197), a nontoxic variant of diphtheria toxin (DT) is widely used carrier protein for polysaccharide conjugate vaccines. Conventionally, CRM197 is isolated by fermentation of Corynebacterium diphtheriae C7 (\u03b2197) cultures, which often suffers from low yield. Recently, several recombinant approaches have been reported with robust processes and higher yields, which will improve the affordability of CRM197-based vaccines. Vaccine manufacturers require detailed analytical information to ensure that the CRM197 meets quality standards and regulatory requirements. In the present manuscript we have described detailed structural characteristics of Escherichia coli based recombinant CRM197 (rCRM197) carrier protein. The crystal structure of the E. coli based rCRM197 was found to be identical with the reported crystal structure of the C7 CRM197 produced in C. diphtheriae C7 strain (Protein Data Bank (PDB) ID: 4EA0). The crystal structure of rCRM197 was determined at 2.3 \u00c5 resolution and structure was submitted to the PDB with accession number ID 5I82. This is the first report of a crystal structure of E. coli derived recombinant CRM197 carrier protein. Furthermore, the rCRM197 was conjugated to Vi polysaccharide to generate Typhoid conjugate vaccine (Vi-rCRM197) and its immunogenicity was evaluated in Balb\/C Mice. The Vi-rCRM197 conjugate vaccine was found to generate strong primary \u03b1-Vi antibody response and also showed a booster response after subsequent vaccination in mice. Overall data suggest that E. coli based recombinant CRM197 exhibits structural and immunological similarity with the C7 CRM197 and can be used as a carrier protein in conjugate vaccine development.<\/jats:p>","DOI":"10.1042\/bsr20180238","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T16:55:19Z","timestamp":1528304119000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Structural and immunological characterization of <i>E. coli<\/i> derived recombinant CRM197 protein used as carrier in conjugate vaccines"],"prefix":"10.1042","volume":"38","author":[{"given":"Ravi P.N.","family":"Mishra","sequence":"first","affiliation":[{"name":"Biological E. Limited, Genome Valley, MN Park, Shameerpet, Hyderabad 500078, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi S.P.","family":"Yadav","sequence":"additional","affiliation":[{"name":"Biological E. Limited, Genome Valley, MN Park, Shameerpet, Hyderabad 500078, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Jones","sequence":"additional","affiliation":[{"name":"National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Nocadello","sequence":"additional","affiliation":[{"name":"Center for Structural Genomics of Infectious Diseases, Northwestern University, Feinberg School of Medicine, Morton Bld. # 7-614 303 E. Chicago Ave., Chicago, IL 60611, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Minasov","sequence":"additional","affiliation":[{"name":"Center for Structural Genomics of Infectious Diseases, Northwestern University, Feinberg School of Medicine, Morton Bld. # 7-614 303 E. Chicago Ave., Chicago, IL 60611, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmilla\u00a0A.","family":"Shuvalova","sequence":"additional","affiliation":[{"name":"Center for Structural Genomics of Infectious Diseases, Northwestern University, Feinberg School of Medicine, Morton Bld. # 7-614 303 E. Chicago Ave., Chicago, IL 60611, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne\u00a0F.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Center for Structural Genomics of Infectious Diseases, Northwestern University, Feinberg School of Medicine, Morton Bld. # 7-614 303 E. Chicago Ave., Chicago, IL 60611, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Goel","sequence":"additional","affiliation":[{"name":"Biological E. Limited, Genome Valley, MN Park, Shameerpet, Hyderabad 500078, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2018,9,25]]},"reference":[{"key":"2021111619125459000_B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2249.2000.01109.x","article-title":"Conjugate vaccines","volume":"119","author":"Goldblatt","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"2021111619125459000_B2","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/nm.2535","article-title":"A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design","volume":"17","author":"Avci","year":"2011","journal-title":"Nat. Med."},{"key":"2021111619125459000_B3","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.4161\/hv.26109","article-title":"Protein carriers of conjugate vaccines: characteristics, development, and clinical trials","volume":"9","author":"Pichichero","year":"2013","journal-title":"Hum. Vacc. Immun."},{"key":"2021111619125459000_B4","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1016\/S0021-9258(19)43810-6","article-title":"Diphtheria toxin and related proteins I. Isolation and properties of mutant proteins serologically related to diphtheria toxin","volume":"248","author":"Uchida","year":"1973","journal-title":"J. Biol. Chem."},{"key":"2021111619125459000_B5","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1093\/nar\/12.10.4063","article-title":"The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197","volume":"12","author":"Giannini","year":"1984","journal-title":"Nucleic Acid Res."},{"key":"2021111619125459000_B6","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/0264-410X(95)00011-O","article-title":"Adjuvants for human vaccines\u2014current status, problems and future prospects","volume":"13","author":"Gupta","year":"1995","journal-title":"Vaccine"},{"key":"2021111619125459000_B7","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1016\/j.vaccine.2010.04.072","article-title":"Overview of the development and current use of CRM197 conjugate vaccines for pediatric use","volume":"28","author":"Shinefield","year":"2010","journal-title":"Vaccine"},{"key":"2021111619125459000_B8","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.vaccine.2010.11.022","article-title":"Vi-CRM197 as a new conjugate vaccine against Salmonella Typhi","volume":"29","author":"Micoli","year":"2011","journal-title":"Vaccine"},{"key":"2021111619125459000_B9","doi-asserted-by":"publisher","first-page":"e47039","DOI":"10.1371\/journal.pone.0047039","article-title":"O: 2-CRM197 conjugates against Salmonella paratyphi A","volume":"7","author":"Micoli","year":"2012","journal-title":"PLoS ONE"},{"key":"2021111619125459000_B10","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/ibd.21800","article-title":"Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study","volume":"18","author":"Fiorino","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"2021111619125459000_B11","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1016\/j.vaccine.2016.03.058","article-title":"Canadian Antimicrobial Resistance Alliance (CARA. Invasive Streptococcus pneumoniae in Canada, 2011\u20132014: characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F","volume":"34","author":"Golden","year":"2016","journal-title":"Vaccine"},{"key":"2021111619125459000_B12","first-page":"1","article-title":"Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection","volume":"20","author":"Cheng","year":"2017","journal-title":"Hum. Vaccine Immunother."},{"key":"2021111619125459000_B13","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1073\/pnas.1701885114","article-title":"Structure of a protective epitope of group B Streptococcus type III capsular polysaccharide","volume":"114","author":"Carboni","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111619125459000_B14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejmech.2017.03.058","article-title":"Synthesis and immunogenicity of PG-tb1 monovalent glycoconjugate","volume":"34","author":"Meng","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"2021111619125459000_B15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.biologicals.2011.05.004","article-title":"Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applications","volume":"39","author":"Br\u00f6ker","year":"2011","journal-title":"Biologicals"},{"key":"2021111619125459000_B16","doi-asserted-by":"publisher","first-page":"5229","DOI":"10.1073\/pnas.1201964109","article-title":"Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197","volume":"109","author":"Malito","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111619125459000_B17","doi-asserted-by":"publisher","DOI":"10.1089\/gen.32.21.23","article-title":"Recombinant production of carrier proteins","volume":"32","author":"Patkar","year":"2012","journal-title":"Genet. Eng. Biotech. News"},{"key":"2021111619125459000_B18","article-title":"Codon optimized polynucleotide for high level expression of CRM197","author":"Goel","year":"2017"},{"key":"2021111619125459000_B19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jbiotec.2011.08.024","article-title":"Overexpression and purification of the recombinant diphtheria toxin variant CRM197 in Escherichia coli","volume":"156","author":"Stefan","year":"2011","journal-title":"J. Biotechnol."},{"key":"2021111619125459000_B20","volume-title":"Molecular Cloning","author":"Sambrook","year":"1989"},{"key":"2021111619125459000_B21","first-page":"50","article-title":"Carrier protein outsourcing","volume":"10","author":"Brady","year":"2012","journal-title":"BioProcess Int."},{"key":"2021111619125459000_B22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev.biochem.70.1.437","article-title":"Analysis of proteins and proteomes by mass spectrometry","volume":"70","author":"Mann","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"2021111619125459000_B23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3891\/acta.chem.scand.04-0283","article-title":"Method for determination of the amino acid sequence in peptides","volume":"4","author":"Edman","year":"1950","journal-title":"Acta Chem. Scand."},{"key":"2021111619125459000_B24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.vaccine.2003.08.003","article-title":"Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines","volume":"22","author":"Metz","year":"2003","journal-title":"Vaccine"},{"key":"2021111619125459000_B25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2174\/187152609789105713","article-title":"Structural genomics and drug discovery for infectious diseases","volume":"9","author":"Anderson","year":"2009","journal-title":"Infect. Disorder Drug Targets"},{"key":"2021111619125459000_B26","first-page":"85","article-title":"High-throughput protein purification for X-ray crystallography and NMR","volume":"75","author":"Kim","year":"2008","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"2021111619125459000_B27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"2021111619125459000_B28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2021111619125459000_B29","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2021111619125459000_B30","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1128\/CVI.00387-10","article-title":"Evaluation of the immunogenicity and biological activity of the Citrobacter freundii Vi-CRM197 conjugate as a vaccine for Salmonella enterica serovar Typhi","volume":"18","author":"Rondini","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"2021111619125459000_B31","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/iai.65.6.2088-2093.1997","article-title":"Synthesis and immunological properties of Vi and di-O-acetyl pectin protein conjugates with adipic acid dihydrazide as the linker","volume":"65","author":"Kossaczka","year":"1997","journal-title":"Infect. Immun."},{"key":"2021111619125459000_B32","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1432-1033.1997.00320.x","article-title":"Comparison of the diphtheria mutant toxin, CRM197, with a Haemophilus influenzae type-b polysaccharide-Crm197 conjugate by optical spectroscopy","volume":"246","author":"Crane","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"2021111619125459000_B33","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1073\/pnas.87.8.2995","article-title":"Diphtheria toxin and its ADP-ribosyltransferase-defective homologue CRM197 possess deoxyribonuclease activity","volume":"87","author":"Bruce","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111619125459000_B34","first-page":"1","article-title":"High level accumulation of soluble diphtheria toxin mutant (CRM197) with co-expression of chaperones in recombinant Escherichia coli","volume":"28","author":"Mahamad","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"2021111619125459000_B35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0014-5793(87)81060-8","article-title":"Conformational changes in diphtheria toxoids: analysis with monoclonal antibodies","volume":"218","author":"Bigio","year":"1987","journal-title":"FEBS Lett."},{"key":"2021111619125459000_B36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1107\/S2059798315023207","article-title":"Crystal structures of the components of the Staphylococcus aureus leukotoxin ED","volume":"72","author":"Nocadello","year":"2016","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"2021111619125459000_B37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1097-2765(00)80008-8","article-title":"Crystal structure of the complex of diphtheria toxin with an extracellular fragment of its receptor","volume":"1","author":"Louie","year":"1997","journal-title":"Mol. Cell"},{"key":"2021111619125459000_B38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1021\/bi962214s","article-title":"Crystal structure of nucleotide-free diphtheria toxin","volume":"36","author":"Bell","year":"1997","journal-title":"Biochemistry"},{"key":"2021111619125459000_B39","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/pro.5560030911","article-title":"Refined structure of dimeric diphtheria toxin at 2.0 \u00c5 resolution","volume":"3","author":"Bennett","year":"1994","journal-title":"Protein Sci."},{"key":"2021111619125459000_B40","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1111\/febs.12783","article-title":"Diphtheria toxin conformational switching at acidic pH","volume":"281","author":"Leka","year":"2014","journal-title":"FEBS J."},{"key":"2021111619125459000_B41","article-title":"Guidelines on the quality, safety and efficacy of typhoid conjugate vaccines","author":"World Health Organization","year":"2013"},{"key":"2021111619125459000_B42","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.12034\/j.issn.1009.606X.217132","article-title":"Expression of CRM197 in E. coli system and its application in universal influenza vaccine","volume":"17","author":"Lu","year":"2017","journal-title":"Chin. J. Process Eng."},{"key":"2021111619125459000_B43","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1016\/j.xphs.2018.03.002","article-title":"Analytical comparability assessments of 5 recombinant CRM197 proteins from different manufacturers and expression systems","volume":"107","author":"Hickey","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"2021111619125459000_B44","doi-asserted-by":"publisher","first-page":"e0189100","DOI":"10.1371\/journal.pone.0189100","article-title":"The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi","volume":"12","author":"Arcuri","year":"2017","journal-title":"PLoS ONE"}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20180238\/809630\/bsr-2018-0238-t.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20180238\/809630\/bsr-2018-0238-t.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T20:11:16Z","timestamp":1637093476000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/38\/5\/BSR20180238\/88201\/Structural-and-immunological-characterization-of-E"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10,31]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20180238","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,25]]},"article-number":"BSR20180238"}}